Card image cap

Elizabeth Warren's Public Statements on Issue: Drugs

Office:
6

Current Issue:

Drugs

Current Speech Type:

Letter

All Debate Executive Order Floor Speech Hearing Interview Issue Position Letter News Article Op-Ed Other Pledge Press Conference Press Release Social Media Speech Statement

Date Range

Keyword Search
Reset Search
Page 1 of 4
Date Title
02/07/2024 Warren, Doggett, King, 75 Lawmakers Urge Biden Administration to Lower Prescription Drug Prices
01/30/2024 Warren, Fetterman, Schumer, Senators Urge Biden Administration to Swiftly Deschedule Marijuana
11/15/2023 Warren, Merkley, Warnock, Blumenauer, 16 Lawmakers Push For New Marijuana Banking Guidance for Fairer Access to Financial Services for Legal Marijuana Businesses
09/28/2022 Letter to Lloyd Austin, Secretary of Defense - Senator Markey Raises Alarm on Fatal Overdoses Among Active Duty Service Members
05/20/2022 Letter to Robert M. Califf, MD, Commissioner of the US Food and Drug Administration - Senator Baldwin, Democratic Colleagues To FDA Commissioner: Remove All Unauthorized E-Cigarettes From Market Immediately
04/25/2022 Warren Urges Biden Administration to Lower Prescription Drug Prices Using Existing Executive Authority
04/11/2022 Letter to Various Pharmaceutical CEOs - Baldwin, Maloney, Hassan, King, Fitzpatrick, Lead Bipartisan, Bicameral Group in Calling on Drug Manufacturers to Make Naloxone Available Over the Counter
03/10/2022 Letter to Robert Califf, Commissioner of the U.S. Food and Drug Administration - Romney, Durbin Lead Colleagues in Urging FDA to Regulate E-Cigarettes after Six Month Delay
03/01/2022 Letter to Stephen J. Ubl, President and CEO of PhRMA - Senator Baldwin, Colleagues Call Out Drug Manufacturers For Squeezing American Families With Rapid and Widespread Price Hikes on Prescription Drugs
02/16/2022 Letter to Merrick Garland, Attorney General Dept. of Justice - SENATORS URGE DOJ TO INVESTIGATE SACKLER FAMILY MEMBERS FOR ROLE IN FUELING OPIOID EPIDEMIC
11/10/2021 Letter to Hon. Joseph R. Biden, President of the United States - Markey, Warren, and Merkley Urge Biden to Issue Blanket Cannabis Pardons
08/23/2021 Letter to Janet Woodcock, Acting Commissioner of Food and Drug Administration - Senators Hassan, Grassley, and Whitehouse Lead Call to FDA to Provide Answers on Potential Conflicts of Interest with Consulting Firm McKinsey in Relation to Opioid Crisis
08/06/2021 Letter to the Honorable Merrick Garland, Attorney General - Warren, Blumenthal, Maloney, and DeSaulnier Urge DOJ to Immediately Appeal Purdue Pharma's Bankruptcy Plan that Would Shield Sackler Family from Accountability for Opioid Crisis
07/26/2021 Letter to Hon. Robert Drain, New York District Judge - Senator Hassan, Colleagues Oppose Purdue Pharma's Request for Bonuses to Top Executives & Employees Amid Ongoing Opioid Epidemic
04/19/2021 Letter to the Hon. Xavier Becerra, Secretary of Health and Human Services - Senator Markey Leads Colleagues in Urging Fda to Ban Menthol Cigarettes
04/16/2021 Letter to the Hon. Xavier Becerra, Secretary of Health and Human Services - Feinstein, Markey, Colleagues Urge FDA to Ban Menthol Cigarettes
02/18/2021 Letter to Joe Biden, President of the United States - Baldwin, Shaheen Lead Colleagues in Calling for Increased Opioid and Substance Use Disorder Funding in President Biden's Budget Proposal
02/18/2021 Letter to Joe Biden, President of the United States - Luján Joins Colleagues in Calling for Increased Opioid and Substance Use Disorder Funding in President Biden's Budget Proposal
11/10/2020 Letter to the Hon. William Barr, Attorney General for the Dept. of Justice - Durbin, Senators Call On DOJ To Stop Plans To Make Purdue Pharma A Public Benefit Corporation
05/22/2020 Letter to Scott Gast, Deputy Counsel to the President - Menendez, Warren, Colleagues Request Newly Appointed "Therapeutics Czar" to Divest from Financial Interest, Resign to Boards of any Pharmaceutical, Medical and Biotech Companies
05/19/2020 Letter to the Hon. Nancy Pelosi, Speaker of the House of Representatives, the Hon. Kevin McCarthy, House Minority Leader, the Hon. Mitch McConnell, Senate Majority Leader, the Hon. Charles Schumer, Senate Minority Leader - U.S. Senators Jeanne Shaheen and Tammy Baldwin Lead Colleagues in Calling for Increased Funding to Treat and Prevent Substance Use Disorders in Coronavirus Relief Package
04/17/2020 Letter to Alex Azar, Sec. of the Dep. of Health and Human Services, and Elinore McCance-Katz, Assistant Secretary for Mental Health and Substance Use - Feinstein, Markey, Warren, Shaheen Call on Trump Administration to Reduce Barriers to Lifesaving Opioid Treatment Medication During Coronavirus Pandemic
02/05/2020 Letter to the Hon. Elinore McCance-Katz, Ph.D., Assistant Secretary for Mental Health and Substance Use for the Substance Abuse and Mental Health Services Administration - Massachusetts Lawmakers Request Information on Federal Plans to Support Mental Health Needs in Puerto Rico Following Recent Earthquakes
01/17/2020 Letter to Hon. Uttam Dhillon, Acting Administrator of the U.S. Drug Enforcement Administration - Congresswoman Kuster, Senators Murray and Warren Press Drug Enforcement Administration on Long-Overdue Steps to Expand Access to Opioid Addiction Treatment
12/17/2019 Letter to the Board of Directors at Perdue Pharma Inc. - Senators Call on Perdue Pharma to Cancel $1.3 Million Bonus for CEO
Page 1 of 4
arrow_upward